PEREGRINE PHARMA (NQ:PPHM)
Delayed: 1.70 +0.08 (4.94%)
Trade Now!
Previous Close $1.62    52 Week High $5.50 
Open $1.70    52 Week Low $0.42 
Day High $1.73    P/E N/A 
Day Low $1.64    EPS $-0.29 
Volume 4,782,509       

Friends, Peers and Foes (?): EDU, NXY, MLNX, ZNGA, LNET (more...)

May 20, 2013 04:16 PM Form 8-K PEREGRINE PHARMACEUTICAL For: May 20
May 20, 2013 09:16 AM Peregrine Pharma (PPHM) Pops Higher on Resumption
May 20, 2013 09:12 AM Peregrine Pharma (PPHM) to resume trading at 9:15am ET
May 20, 2013 08:48 AM Peregrine Pharma (PPHM), FDA Reach Agreement Over Bavituximab Phase III Design
May 20, 2013 08:47 AM Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
May 20, 2013 08:42 AM Peregrine Pharmaceuticals, Inc. (PPHM) halted, news pending
May 16, 2013 08:30 AM Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual Meeting
May 8, 2013 08:34 PM Form 4 PEREGRINE PHARMACEUTICAL For: May 06 Filed by: Ziebell Mark R
May 8, 2013 08:31 PM Form 4 PEREGRINE PHARMACEUTICAL For: May 06 Filed by: SWARTZ ERIC S
May 8, 2013 08:30 PM Form 4 PEREGRINE PHARMACEUTICAL For: May 06 Filed by: Shan Joseph
View All Articles

Entities mentioned with PPHM

View All Entities